Professional Documents
Culture Documents
Difficult Cases Septic Shock
Difficult Cases Septic Shock
SEPTIC SHOCK
Warren Rodrigues
29th May 2019
Sepsis
Sepsis is defined as
(a) a life threatening organ dysfunction
that is caused by
(b) a dysregulated host response to infection
Septic Shock
‘Circulatory and Cellular/Metabolic
abnormalities are profound enough to
substantially increase mortality’.
DEFINITIONS
• SEPSIS: Systemic inflammatory response to
infection
• SEVERE SEPSIS: Organ Dysfunction,
Hypotension and Hypoperfusion
• SEPTIC SHOCK: Severe Sepsis that persists
despite adequate fluid replacement
• REFRACTORY SEPTIC SHOCK: Shock despite goal- directed
use of inotropes, vasopressors, vasodilators, and
maintenance of metabolic and hormonal homeostasis
2014
update
Nature Reviews/Immunology Volume 17/July 17
Plan:
• 1. HFOV
• 2. Inotropes as required
• 3. Continue with steroids
• 4. Microbiology and ID consult
• 5. Resend meningococcal PCR
Cardiac Arrest-PICU
ABG-pH 7.125 7.34 6.94 7.06
pCO2 5.84 3.03 7.25
pO2 8 6.9 5.7
HCO3 14.5 12.6 16.3
BE -15 -13 -15
Sao2 82% 88% 51% 48%
Lactate 4.14 5.91 10.53 17.98
Subsequent Clinical Course
• 3 periods of Cardiac Arrest within an hour. APLS algorithm
followed.
• 1st: 8 minute arrest. Good CPR throughout.
• 2nd: 24 minutes. Good quality CPR throughout. Bagged
with ETT in situ. 6 x adrenaline, calcium and bicarbonate.
Echo performed early during 2nd arrest. No ventricular
output. During arrest, ECMO team contacted
• 3rd: 8 minutes. Probably related to hyperkalaemia (K: 7.4)
3 further Adrenaline, Calcium Gluconate and Sodium
bicarbonate. Insulin Dextrose infused.
• DISADVANTAGES:
Specialty Cardiac Services
Risk of Mediastinitis
Risk of local Haemorrhage greater than percutaneous
technique
• 18 year period, ECMO: 441 patients
• 1988-2006
• Cardiac Arrest: 18
Decannulated: 18 (78%)
• Haemolysis!
• Plasma Free Hb monitoring
• Maximise canullae size
• Minimize presence of low flow zones (circuit
bridges, number of taps and access points)
Outcomes in Sepsis
• Neonatal Sepsis: 75%
• Neonatal HSV infection: 25%
• Bordetella pertussis: lower than HSV
• Children with isolated Bacterial and Viral Pneumonia: 59% & 65%
• Adults with isolated Bacterial and Viral Pneumonia: 61% & 66%.
• Combined Survival in Adults and Children with ARDS: 54% (all ARDS)
• Sepsis induced ARDS more or less similar to above
• Paediatric Septic Shock: Survival to hospital discharge is 50%
• Paediatric High Flow C VA ECMO: 75%
• Allogenic Bone Marrow Transplant: Dismal outcomes
• Stem cell transplantation: 10% to hospital discharge
Case – 2
• 2 ½ year old female, 12 kg.
• ECMO referral for hypercapnic respiratory failure (Influenza B, RSV
positive, bilateral pneumothoces and pleural effusions)
• Presented to local unit with 7 days history of worsening breathing
difficulties, fever and cough.
• Treated with Optiflow, CoAmoxiclav, Ceftriaxone, Clarithromicin and
Hydrocortisone.
• Respiratory Deterioration requiring intubation and ventilation and
transfer to tertiary PICU where she continued to deteriorate
requiring increasing oxygen and ventilatory pressures.
• Pulmonary air leak syndrome
• She had multiple chest drain insertions with manipulations, bilateral
pneumothorax and pleural effusion, 3 drains on suction (1 left and 2
right)
• Inotropy: Nor Adrenaline 0.05mics/kg/minute
Radiology
Consultant Note
• Explained ECMO offers lung rest with chance of healing.
Children in X’s situation on ECMO have around 75% chance of
recovery. There is a risk of bleeding, brain injury but
emphasised that there are also considerable risks with
conventional treatment and it is difficult for her lungs to heal
on high pressure ventilation.
• After discussions parents said they want to go ahead with
ECMO.
CXR
VA ECMO:
12 Fr R carotid,
17Fr RIJV.
ECMO Course & Update
• Infection: Severe necrotising pneumonia with RSV, Flu B, Candida and PCR positive for
Pneumococcus. No history of recurrent infections, poor growth.
• Days prior to ECMO- No known frank collapse or hypotension, Prolonged hypoxia –
• Fairly stable on ECMO, but poor lung recovery - SaO2 in mid- 70s
• Sedated - slowly weaning of Opiods.
• No spontaneous eye opening
• Coughing and moving all limbs
• EEG "encephalopathy“, CT Head Normal
• Ciprofloxacin, Piptazobactam, Oseltamivir
• Anti-coagulation: as per protocol
• Echo normal
• Renal function and LFT normal
• Lactate 1.9-2.5
• Day 28
CT Chest
Decision?
• 4 weeks- VA ecmo- 160-170% ECMO Flows
• CT Thorax
• Manipulation of chest drain as intermittently blocked
• Cannulae re- positioned
• Flexible bronchoscopy -> tube obstructed
• High Plasma free Hb (3.8) - No end organ damage
• Air leak - ?Bronchopleural fistula - Improved
• Airway occlusion by secretions - Improved after Bronchoscopy
• White out lungs - Necrotising pneumonia LLL, RLL, R middle lobe & lingula,
sparing upper lobes.
• Abdominal distension (spleen and liver displaced vs enlarged), Medical Pancreatitis
• CRP>270, but negative cultures and Pro-Calcitonin 0.1ng/ml
• She failed to make significant clinical improvement despite
prolonged mechanical support for 4 weeks
After 4 week of V-A ECMO
What was done and how?
• Consensus opinion was that conversion to VV ECMO
was the next sensible step.
• Staged approach VA→VAV→VV
Plan
• Perfusion
• Surgeon/ Interventional Cardiologist
• Fluroscopy/ Echocardiography
• Deep Hypothermia
• Avalon Canulla
• Y connector
• Gate Clamp
• Flow probes
Fluoroscopy
Fluoroscopy
Avalon Canulla Inserted
A
CXR
VAV